Sleep Quality After Nasosinusal Surgery in AERD Patients
1 other identifier
interventional
32
1 country
1
Brief Summary
Aspirin exacerbated respiratory disease presents as a triad composed by asthma, eosinophilic rinosinusitis and intolerance to aspirin and NSAIDS. In subjects with chronic rhinosinusitis sleep alterations have been found, with important improvement after surgery, but those alterations and improvements have not been studied in patients diagnosed with AERD who, due to their comorbidities, may present more severe pre surgical symptoms and a more important post-surgical improvement. The investigators aim to study patients with AERD sleep, quality of life and symptoms before surgery, and one, three and six months post-surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 4, 2018
CompletedFirst Posted
Study publicly available on registry
August 13, 2018
CompletedStudy Start
First participant enrolled
September 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedFebruary 7, 2019
February 1, 2019
1.3 years
July 4, 2018
February 6, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Subjective sleep quality assessed by the Pittsburgh sleep quality index.
Total score in Pittsburgh sleep quality index, basal and after surgery. Total score in Pittsburgh sleep quality index, before and after surgery. The Pittsburgh sleep quality index has a global score in which a higher score indicates a worse sleep quality, with a global score higher than five differentiating those with good and bad sleep quality. In order to obtain the global score, individual questions are grouped in seven components, to which a 0 to 3 score is assigned and all components scores are added. The total range of the global score goes from 0 to 21.
6 months
Secondary Outcomes (4)
Objective sleep quality assessed by actigraphy.
Basal; 3 and 6 months
Quality of life assessed by the Asthma Quality of Life Questionnaire
Basal; 1, 3 and 6 months
Nasal symptoms assessed by the SNOT - 22
Basal; 1, 3 and 6 months
Asthma symptoms assessed by the Asthma Control Test.
Basal; 1, 3 and 6 months
Study Arms (1)
AERD patients
EXPERIMENTALPatients managed with Endoscopic sinus surgery for treatment of AERD.
Interventions
Eligibility Criteria
You may qualify if:
- AERD patients.
- Cumbersome nasal polyposis with poor treatment response
You may not qualify if:
- Previously diagnosed sleep disorder.
- Psychiatric disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto Nacional de Enfermedades Respiratorias
Mexico City, Mexico City, 14080, Mexico
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 4, 2018
First Posted
August 13, 2018
Study Start
September 1, 2018
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
February 7, 2019
Record last verified: 2019-02